Clinician barriers, perceptions, and practices in treating patients with hepatitis C virus and substance use disorder in the United States

The likelihood of clinicians prescribing direct-acting antiviral (DAA) therapy for patients with chronic hepatitis C virus (HCV) and substance use disorder (SUD) was assessed via a survey emailed throughout the United States to clinicians (physicians and advanced practice providers) in gastroenterol...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Haesuk, Brown, Carolyn, Wilson, Debbie L., Huang, Pei-Lin, Hernández-Con, Pilar, Horne, Patrick, Goodin, Amie, Joseph, Amanda, Segal, Rich, Cabrera, Roniel, Cook, Robert L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2023
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971512/
https://www.ncbi.nlm.nih.gov/pubmed/36865395
http://dx.doi.org/10.1016/j.pmedr.2023.102138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971512/
https://www.ncbi.nlm.nih.gov/pubmed/36865395
http://dx.doi.org/10.1016/j.pmedr.2023.102138

Ejemplares similares